1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study
(
- Contribution to journal › Article
- 2017
-
Mark
Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34+CD38- stem and progenitor cells in chronic myeloid leukemia
(
- Contribution to journal › Article
- 2016
-
Mark
Evaluating the role of leukotriene-modifying drugs in asthma management : Are their benefits ‘losing in translation’?
(
- Contribution to journal › Scientific review
- 2013
-
Mark
The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells
(
- Contribution to journal › Article
-
Mark
The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma
(
- Contribution to journal › Article
- 2010
-
Mark
Crystal structure of leukotriene A(4) hydrolase in complex with kelatorphan, implications for design of zinc metallopeptidase inhibitors
(
- Contribution to journal › Article
- 2009
-
Mark
Signaling and regulation of cysteinyl leukotriene receptors in intestinal epithelial cells and colon cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Lipid metabolites as regulators of airway smooth muscle function
(
- Contribution to journal › Article
- 2006
-
Mark
Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate.
(
- Contribution to journal › Article
- 2003
-
Mark
Molecular Pharmacology and Structure Function Modelling of the Leukotriene B4 Receptor BLT1
2003)(
- Thesis › Doctoral thesis (compilation)